Advanced Clinical Laboratory Solutions Teams Up with OpiSafe, Offers Physicians Optimal Approach for Prescribing, Managing and Monitoring Opioid Abuse

Advanced Clinical Laboratory Solutions Teams Up with OpiSafe, Offers Physicians Optimal Approach for Prescribing, Managing and Monitoring Opioid Abuse

BROOKLYN, NY – September 6, 2016 – Responding to the national crisis of over two million people in the U.S. suffering from substance use disorders related to prescription opioid pain relievers, Advanced Clinical Laboratory Solutions, Inc. (ACLS) offers physicians and their patients the benefits of OpiSafe, a comprehensive platform of solutions that perform risk stratification for each patient on the basis of morphine equivalent dosing ranges, pain and function scores, opioid misuse risk scores and automated Prescription Drug Monitoring Program (PDMP) checks. ACLS is an independent clinical laboratory specializing in clinical toxicology and pharmacogenetics that provides convenient, high-quality testing services and accurate, timely test results to patients, physicians and medical centers in 20+ states.

“With an estimated 249 million prescriptions for opioids written annually by healthcare providers — enough prescriptions for every American adult to have a bottle of pills — OpiSafe provides valuable guidance on the safe use of opioids for treating pain more effectively,” says Leon Reyfman, M.D., CEO, ACLS. “Physicians report that OpiSafe has become an integral part of their practices, saving them time and creating peace of mind.”

OpiSafe measures pain, function, opioid misuse risk, co-morbid depression, anxiety and sleep disorders, all via a simple tandem app called OpiSafe Teamwork. Key features include risk assessments, guideline adherence, automated PDMP checks with almost instant reports, and patient monitoring in-office and out-of-office. The solution also engages patients through smartphone and web-based platforms, generating patient feedback on an ongoing basis.

Dr. Reyfman points to the alarming increase in opioid overdose deaths, which have quadrupled since 1999, and the concurrent, marked increase in opioid prescriptions.

“As a result of these devastating reports, directives from public and private sectors now urge clinicians to utilize urine drug testing before starting opioid therapy and at least annually,” he says.  “The goal is to assess for prescribed medications, as well as other controlled prescription drugs and illicit drugs.”

He also highlights the need for clinicians to educate themselves on treating pain safely and effectively, and to communicate with patients about the risks and benefits of opioid therapy for chronic pain.

“As a nation, we must improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose,” advises Dr. Reyfman.

About ACLS
ACLS is a provider of diagnostic laboratory testing, information and services that enable physicians and other healthcare professionals to make decisions to improve health. Clinical laboratory testing is an essential element in the delivery of healthcare services. Physicians use laboratory tests to assist in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. Visit

CPR Communications
Nathan Molinari;
201.641.1911 x 22

Leave a Reply

Your email address will not be published. Required fields are marked *

13 + twelve =